Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Statin Stories

2013-09-04 12:32:23

JUPITER study data published in Circulation, suggest HDL-P may be a better marker of residual risk than HDL cholesterol or apolipoprotein A-1 in patients on statin therapy RALEIGH, N.C., Sept. 4, 2013 /PRNewswire/ -- LipoScience, Inc., (NASDAQ: LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced the publication of data...

2013-09-03 10:37:43

This model has the potential to help doctors better triage patients with potentially fatal syndrome Researchers from Brigham and Women's Hospital (BWH) have developed a risk score calculation that can help predict which patients with rhabdomyolysis (a condition that occurs due to muscle damage) may be at risk for the severe complication of kidney failure or death. This research will publish online September 2, 2013 in JAMA Internal Medicine. Rhabdomyolysis occurs when muscles are...

2013-09-03 08:28:32

"In patients with low HDL receiving RVX-208 and Rosuvastatin (Crestor(®)), plaque regression was twice as pronounced as compared to the pre-specified primary endpoint." TSX Exchange Symbol: RVX CALGARY, Sept. 3, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) today announced the Full Analysis Set (FAS) data from 281 treated patients in its Phase 2b ASSURE clinical trial evaluating RVX-208 using intravascular ultrasound (IVUS) in high-risk cardiovascular patients. Current...

Statin Benefits For Dementia And Cataracts
2013-09-03 05:10:21

redOrbit Staff & Wire Reports - Your Universe Online An inexpensive and commonly used cholesterol medication could be used to prevent cataracts and reduce a person’s risk of developing dementia, according to research presented over the weekend at the European Society of Cardiology (ESC) Congress in Amsterdam. In one study, Dr. Tin-Tse Lin and colleagues studied nearly 58,000 Taiwanese patients, and found taking high-potency statins reduced their risk of developing...

2013-09-01 04:20:27

Pooled Data from Four Phase 2 Studies Demonstrated Consistent Reductions in LDL Cholesterol of Up to 59 Percent THOUSAND OAKS, Calif., Aug. 31, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced treatment with AMG 145 resulted in significant reductions in low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, of up to 59 percent in an efficacy analysis of pooled data from four 12-week Phase 2 studies evaluating AMG 145 in patient populations with high...

2013-08-21 08:25:56

CAMBRIDGE, Mass., Aug. 21, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals Inc. today announced the initiation of PATHWAYS I*, a Phase 2 trial investigating the safety, tolerability and efficacy of CAT-2003, an oral SMART Linker conjugate constructed using the company's proprietary technology. CAT-2003 will be evaluated in patients with hypertriglyceridemia and in combination with statins in patients with hypercholesterolemia. "We recently announced positive Phase 1 data showing...

2013-08-15 23:25:53

Healthy Directions, a leading source of natural health advice and doctor-formulated nutritional products, and its expert integrative cardiologist are offering a one-hour webinar on heart health and cholesterol. Potomac, MD (PRWEB) August 15, 2013 Healthy Directions, LLC, today announced that its expert, and widely recognized, integrative cardiologist, Stephen Sinatra, MD, is hosting a free interactive heart health webinar on Thursday, September 19, 2013 at 2:00 p.m. EDT. Registration for...

2013-08-15 23:25:18

The same drugs that are used to lower cholesterol may one day be used to fight cancers like mesothelioma. That is the finding of a new study conducted in Japan and reported by Surviving Mesothelioma. Raleigh, NC (PRWEB) August 15, 2013 In a recent study on statins and malignant mesothelioma, Japanese researchers combined two of the most popular statin drugs, Zocor and Lipitor, with a form of vitamin E called gamma tocotrienol (y-T3). The y-T3 alone had a negative impact on mesothelioma...

2013-08-13 23:21:15

A few factors that boost the odds of having a stroke can't be changed like age and family history. But there are a surprising number of things that can be done to prevent stroke. Boston, MA (PRWEB) August 13, 2013 More than two dozen factors influence the odds of having a stroke. Some can't be changed like getting older or having a family history of stroke. But a surprising number of these factors can be controlled, even when an underlying medical condition further ups the risk of...

2013-08-12 14:16:37

The growth of deadly plaque inside the walls of arteries may not happen as scientists believed, research from the University of Toronto and Massachusetts General Hospital has found. The research also suggests a new potential target in the treatment of atherosclerosis, a leading cause of cardiovascular disease and death globally. The research team found that macrophages, white blood cells that drive atherosclerosis, replicate inside plaques. Moreover, this growth is not reliant on cells...